Cleared Traditional

K984627 - AVE 4F SITESEER CARDIOVASCULAR ANGIOGRA...

K984627 is an FDA 510(k) clearance for AVE 4F SITESEER CARDIOVASCULAR ANGIOGRA..., manufactured by Arterial Vascular Engineering, Inc.. The device is a Class 2 Cardiovascular device with product code DQO cleared through the Traditional 510(k) pathway after a 209-day FDA review.

K984627 · Arterial Vascular Engineering, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1999
Decision
209d
Days
Class 2
Risk

K984627 is an FDA 510(k) clearance for the AVE 4F SITESEER CARDIOVASCULAR ANGIOGRAPHIC CATHETER. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Arterial Vascular Engineering, Inc. (Billerica, US). The FDA issued a Cleared decision on July 27, 1999 after a review of 209 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Arterial Vascular Engineering, Inc. devices

FDA 510(k) Submission Details - K984627

510(k) Number K984627 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 30, 1998
Decision Date July 27, 1999
Days to Decision 209 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
84d slower than avg
Panel avg: 125d · This submission: 209d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQO Device Classification - Class 2, Special Controls

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 307
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K984627.
CORDIS SUPER TORQUE MB ANGIOGRAPHIC CATHETER WITH RADIOPAQUE MARKER BANDS
K992347 · Cordis Corp. · Oct 1999
SCIMED IMPULSE ANGIOGRAPHIC CATHETERS
K992123 · Boston Scientific Scimed, Inc. · Aug 1999
RADIFOCUS OPTITORQUE
K992051 · Terumo Medical Corp. · Aug 1999
CORDIS TEMPO ANGIOGRAPHY CATHETER
K991673 · Cordis Corp. · May 1999
SPYGLASS 5 FR ANGIOGRAPHIC CATHETER
K982299 · Daig Corp. · Oct 1998
ENVY GUIDING CATHETER
K974774 · Cook, Inc. · Oct 1998